title: Ifchannel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.
authors: Icahn School of Medicine at Mount Sinai, New York, NY, United States; Division of Cardiology, Elmhurst Hospital Center, Elmhurst, NY, United States. Electronic address: madiasj@nychhc.org.
authors: John E
authors: JE
authors: Madias
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology*; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000037:antagonists & inhibitors*; D006801:Humans; D000077550:Ivabradine; D018579:Patient Selection; D013616:Tachycardia, Sinus / Q000188:drug therapy / Q000209:etiology; D054549:Takotsubo Cardiomyopathy / Q000150:complications / Q000378:metabolism / Q000503:physiopathology
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine
keywords: Heart failure in takotsubo syndrome; Ivabradine in sinus tachycardia; Levosimendan and takotsubo syndrome; Management of takotsubo syndrome; Takotsubo syndrome; β-blockers and takotsubo syndrome